Globus Medical GMED Unrecognized compensation cost related to non-vested awards

Unrecognized compensation cost related to non-vested awards at other companies

AbbottABT

——

FortiveFTV

——

Other financials

Income statement

See full

Revenue$759.9M+27.0%

Gross profit$525.8M+30.6%

Operating income$150.4M+55.0%

Net income$124.3M+64.7%

EPS (diluted)$0.90+66.7%

Balance sheet

See full

Cash & equivalents$561.0M+21.6%

Total debt$116.3M+25.0%

Total equity$4.7B+15.8%

Total assets$5.4B+15.5%

Cash flow

See full

Operating cash flow$202.4M+14.1%

CapEx$39.6M+9.7%

Free cash flow$162.7M+15.3%

Valuation

See full

Market cap$10.76B+15.7%

Enterprise value$10.31B+15.6%

P/E18.3×-31.7×

P/S3.5×-0.2×

Profitability

See full

Gross margin67.9%+7.3pp

Operating margin17.2%+7.0pp

Net margin18.9%+11.5pp

FCF margin19.7%-1.1pp

Returns & leverage

See full

Return on equity13.3%+8.7pp

Debt / equity0×0.0×

Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's unrecognized compensation cost related to non-vested awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Globus Medical's unrecognized compensation cost related to non-vested awards?: Globus Medical (GMED) reported unrecognized compensation cost related to non-vested awards of $129.4M in Q1 2026.
How has Globus Medical's unrecognized compensation cost related to non-vested awards changed year-over-year?: Globus Medical's unrecognized compensation cost related to non-vested awards decreased by 0.9% year-over-year, from $130.6M to $129.4M.